| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.06B | -16.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.01B | -55.7% |
| Gross margin | 62.0% | Net margin 15.9% |
| Revenue Q/Q | -78.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.02B | 38.0% |
| R&D | ¥0.00B | 3.2% |
| SG&A | ¥0.03B | 40.4% |
| Tax & other | ¥0.01B | 9.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
睿智医药 ・ 世纪瑞尔 ・ 昌红科技 ・ *ST动力 ・ 科泰电源 ・ 瑞凌股份 ・ 安居宝 ・ 新锦动力 ・ 振东制药 ・ 新研股份 ・ 秀强股份 ・ 华中数控
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies